Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naltrexzone Specijalna BolnicafiledCriticalNaltrexzone Specijalna Bolnica
Priority to RS20130177ApriorityCriticalpatent/RS20130177A1/en
Publication of RS20130177A1publicationCriticalpatent/RS20130177A1/en
Invention herewith described refers to the pharmaceutical implant, which provides the adjusted sustained release of the active agent during a prolonged period of time of at least three months, whereat the therapeutic doses are without initial burst release of the active agent after dosing. The pharmaceutical implant comprises: the external part prepared from one or more layers of the biodegradable polymer, which stays whole for a long period of more than 3 months after implementation in situ in a patient while allowing the active agent to expand from the implant into the inner part, which is composed of several microcapsules with a biodegradable polymer and at least one active agent, whereat the microcapsules are compacted under pressure in the form of tablets to stop the release of the of active agent dose from the microcapsule.
RS20130177A2013-05-082013-05-08The pharmaceutical remedy with extended release and the procedure of its dosage
RS20130177A1
(en)
Solid pharmaceutical dosage unit of oral disintegration comprising an estetrol component; Preparation method; use for female contraception and in female hormone replacement therapy.
Stable anti-tuberculosis pharmaceutical composition in a form of a redispersible tablet comprising isoniazid granules and rifapentin granules and their preparation process
STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS